MediSave can be used to pay for the cost of the vaccine after subsidies from 2026. Read more at straitstimes.com.
Subsidies and existing MediSave schemes could possibly bring the out-of-pocket cost of Shingrix down to zero, says Health ...
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) reflecting updated views and recent competitive ...
GlobalData on MSN16d
GSK stays optimistic on vaccines amidst US and China woesWhile vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
(Sharecast News) - GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the European Medicines Agency. Shringrix, which has already ...
Singapore will begin providing subsidies and allow individuals to use their personal medical savings for shingles ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK is also investigating submission of this presentation to other markets. GSK’s shingles vaccine has been approved in the European Union for the prevention of herpes zoster (HZ) and post-herpetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback